iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by CENTRAL TRUST Co

CENTRAL TRUST Co trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,290 shares of the financial services provider’s stock after selling 200 shares during the quarter. CENTRAL TRUST Co’s holdings in iShares Biotechnology ETF were worth $1,889,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in IBB. Huntington National Bank raised its holdings in iShares Biotechnology ETF by 17.9% during the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after purchasing an additional 160 shares in the last quarter. National Bank of Canada FI raised its stake in shares of iShares Biotechnology ETF by 5.9% in the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after buying an additional 229 shares in the last quarter. Avior Wealth Management LLC lifted its holdings in shares of iShares Biotechnology ETF by 438.2% in the third quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock valued at $470,000 after buying an additional 2,629 shares during the period. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares in the last quarter. Finally, Main Management ETF Advisors LLC grew its holdings in iShares Biotechnology ETF by 2.5% during the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after acquiring an additional 14,535 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.2 %

Shares of iShares Biotechnology ETF stock opened at $138.66 on Monday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The company’s 50-day moving average price is $136.37 and its two-hundred day moving average price is $141.55.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.